Here are the 10-Q quarterly reports from GP-Act III Acquisition Corp. Units (GPATU) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow GPATU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GPATU filings page.
GP-Act III Acquisition Corp., a Cayman Islands SPAC, reported June 30, 2026 results while still seeking an initial business combination. Total assets were $98.4 million, almost entirely marketable securities in the Trust Account of $98.2 million after significant redemptions.
For the six months ended June 30, 2026, the company recorded net income of $2.44 million, driven by $4.48 million of interest on Trust investments, partially offset by $2.03 million of general and administrative expenses. During the extension vote, holders of 19,776,272 Class A shares redeemed for about $215.4 million, leaving 8,973,728 Class A shares subject to redemption at $10.95 per share.
Liquidity outside the Trust is tight, with cash of $10,586, a working capital deficit of $2.26 million, and $595,000 outstanding on related-party promissory notes. The business combination deadline was extended to November 13, 2026, and management disclosed that these liquidity conditions and the mandatory liquidation date raise substantial doubt about the company’s ability to continue as a going concern.
GP-Act III Acquisition Corp. is a SPAC that has not yet completed a business combination and continues to earn only interest on its IPO proceeds. For the quarter ended March 31, 2026, it reported net income of $2.15 million, driven by $2.72 million of interest on trust investments, partially offset by $0.57 million of general and administrative expenses.
Cash outside the trust was $119,428, while the trust held $311.9 million invested mainly in Treasury-focused money market funds. The company carries a working capital deficit and discloses that the mandatory liquidation deadline of November 13, 2026 raises substantial doubt about its ability to continue as a going concern unless a merger closes in time.
Subsequent to quarter-end, shareholders approved an extension of the deadline from May to November 2026 but redeemed 19,776,272 Class A shares for about $215.4 million, leaving roughly $97.8 million in the trust. All 7,187,500 founder Class B shares were converted into Class A, resulting in 35,937,500 Class A shares outstanding.